​
​

bluebird bio (BLUE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

bluebird bio Revenue Highlights

Latest Revenue (Y)

$3.60M

Latest Revenue (Q)

$16.10M

Main Segment (Y)

Product

bluebird bio Revenue by Period

bluebird bio Revenue by Year

DateRevenueChange
2022-12-31$3.60M-1.77%
2021-12-31$3.66M-98.54%
2020-12-31$250.73M461.25%
2019-12-31$44.67M-18.15%
2018-12-31$54.58M54.06%
2017-12-31$35.43M475.58%
2016-12-31$6.16M-56.28%
2015-12-31$14.08M-44.62%
2014-12-31$25.42M25.97%
2013-12-31$20.18M5835.59%
2012-12-31$340.00K-61.45%
2011-12-31$882.00K-

bluebird bio generated $3.60M in revenue during NA 2022, up -1.77% compared to the previous quarter, and up 10.15% compared to the same period a year ago.

bluebird bio Revenue by Quarter

DateRevenueChange
2024-06-30$16.10M-13.31%
2024-03-31$18.57M137.08%
2023-12-31$7.83M-36.78%
2023-09-30$12.39M79.85%
2023-06-30$6.89M189.37%
2023-03-31$2.38M3740.32%
2022-12-31$62.00K-12.68%
2022-09-30$71.00K-95.33%
2022-06-30$1.52M-21.90%
2022-03-31$1.95M21.11%
2021-12-31$1.61M-92.92%
2021-09-30$22.68M203.49%
2021-06-30$7.47M-41.60%
2021-03-31$12.79M19.48%
2020-12-31$10.71M-44.44%
2020-09-30$19.27M-90.31%
2020-06-30$198.89M809.71%
2020-03-31$21.86M118.70%
2019-12-31$10.00M12.20%
2019-09-30$8.91M-32.99%
2019-06-30$13.30M6.62%
2019-03-31$12.47M-35.19%
2018-12-31$19.24M66.92%
2018-09-30$11.53M46.83%
2018-06-30$7.85M-50.80%
2018-03-31$15.96M282.85%
2017-12-31$4.17M-45.95%
2017-09-30$7.71M-53.87%
2017-06-30$16.72M144.67%
2017-03-31$6.83M340.21%
2016-12-31$1.55M-
2016-09-30$1.55M-
2016-06-30$1.55M3.54%
2016-03-31$1.50M1.83%
2015-12-31$1.47M11.18%
2015-09-30$1.32M-73.20%
2015-06-30$4.94M-22.13%
2015-03-31$6.34M-0.66%
2014-12-31$6.39M0.33%
2014-09-30$6.37M0.47%
2014-06-30$6.33M-
2014-03-31$6.33M-
2013-12-31$6.33M-0.78%
2013-09-30$6.38M0.81%
2013-06-30$6.33M462.02%
2013-03-31$1.13M1225.88%
2012-12-31$85.00K-
2012-09-30$85.00K-
2012-06-30$85.00K-
2012-03-31$85.00K-

bluebird bio generated $16.10M in revenue during Q2 2024, up -13.31% compared to the previous quarter, and up 676.23% compared to the same period a year ago.

bluebird bio Revenue Breakdown

bluebird bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19Dec 18
Other Revenue$858.00K$812.00K---
Product$2.74M$2.85M---
Royalty And Other Revenue--$21.08M--
Service--$114.06M--
License And Royalty---$8.21M$2.23M
Collaboration Arrangement---$36.47M$1.60M
Royalty----$2.20M

bluebird bio's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (76.15%), and Other Revenue (23.85%).

Quarterly Revenue by Product

Product/ServiceSep 23Jun 23Mar 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Royalty And Other Revenue$111.00K$53.00K$85.00K$71.00K$188.00K$537.00K$1.53M$488.00K$5.36M$3.99M$3.50M$10.86M--------
Product$12.28M$6.84M$2.30M-$1.33M$1.41M--------------
Service------$6.31M$5.31M$5.92M$5.52M$13.35M$78.36M$16.83M-------
License And Royalty------------$2.73M$2.84M$2.33M$1.74M$1.29M$861.00K--
Collaboration Arrangement-------------$7.16M$6.58M$11.56M$11.18M---
Royalty-----------------$800.00K$600.00K$400.00K

bluebird bio's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Product (99.10%), and Royalty And Other Revenue (0.90%).

bluebird bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SRPTSarepta Therapeutics$1.24B$362.93M
PTCTPTC Therapeutics$937.82M$135.42M
KPTIKaryopharm Therapeutics$146.03M$29.52M
TVTXTravere Therapeutics$145.24M$62.90M
VIRVir Bio$86.18M$2.38M
YMABY-mAbs Therapeutics$84.82M$18.46M
CVACCureVac$52.70M$12.37M
KRYSKrystal Biotech$50.70M$83.84M
MRSNMersana Therapeutics$36.85M$12.60M
AGIOAgios Pharmaceuticals$26.82M$8.96M
BLUEbluebird bio$3.60M$16.10M
VKTXViking Therapeutics--
MDGLMadrigal Pharmaceuticals-$62.17M
ZNTLZentalis Pharmaceuticals--
HEPAHepion Pharmaceuticals--

BLUE Revenue FAQ

What is bluebird bio’s yearly revenue?

bluebird bio's yearly revenue for 2022 was $3.6M, representing a decrease of -1.77% compared to 2021. The company's yearly revenue for 2021 was $3.66M, representing a decrease of -98.54% compared to 2020. BLUE's yearly revenue for 2020 was $250.73M, representing an increase of 461.25% compared to 2019.

What is bluebird bio’s quarterly revenue?

bluebird bio's quarterly revenue for Q2 2024 was $16.1M, a -13.31% decrease from the previous quarter (Q1 2024), and a 133.69% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.57M, a 137.08% increase from the previous quarter (Q4 2023), and a 680.05% increase year-over-year (Q1 2023). BLUE's quarterly revenue for Q4 2023 was $7.83M, a -36.78% decrease from the previous quarter (Q3 2023), and a 12535.48% increase year-over-year (Q4 2022).

What is bluebird bio’s revenue growth rate?

bluebird bio's revenue growth rate for the last 3 years (2020-2022) was -98.57%, and for the last 5 years (2018-2022) was -93.41%.

What are bluebird bio’s revenue streams?

bluebird bio's revenue streams in c 22 are Other Revenue, and Product. Other Revenue generated $858K in revenue, accounting 23.85% of the company's total revenue, up 5.67% year-over-year. Product generated $2.74M in revenue, accounting 76.15% of the company's total revenue, down -3.89% year-over-year.

What is bluebird bio’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of bluebird bio was Product. This segment made a revenue of $2.74M, representing 76.15% of the company's total revenue.